.png)
New KIR-CAR T cell therapy shows promise in multiple solid cancers
The first Phase I clinical trial uses a CAR T cell therapy inspired by natural killer (NK) cells, designed to reduce T cell exhaustion.
Latest content
- 1405/04/23 Novel Strategy Could Make Stem Cell Transplants Safer
- 1405/04/04 World’s First Clinical Trial Using Embryonic Stem Cells to Treat Huntington’s Disease Launches
- 1405/04/04 Extension of the Application Deadline for the First Research Fellowship Call at Tehran University of Medical Sciences
- 1405/03/14 Identification of a protein that may limit the effectiveness of CAR-T therapy against cancer
- 1405/03/14 Stem Cell Transplantation Found More Cost-Effective Than Gene Therapy for Sickle Cell Disease Patients
- 1405/03/12 Understanding Cell Therapy
- 1405/03/09 Early results of a PCSK9-targeting gene therapy for treating high cholesterol appear promising.
_1.png)
Pediatric Cell and Gene Therapy Research Center
Tehran University of Medical Sciences
- : 02161472396
- Fax : 02166948444
- Postal code : 1417613151
- email: pcgtrc@tums.ac.ir
